Dr. Vicente Anido, Jr.
And finally this week, Aerie Pharmaceuticals has named Dr. Vicente Anido, Jr. - a veteran in the industry and President and CEO of ISTA Pharmaceuticals prior to its acquisition by Bausch + Lomb - as Chairman of its Board.
Dr. Thomas van Haarlem, Aerie’s President and CEO welcomed his new Chairman and said he looked “forward to his contributions to Aerie’s continuing success in advancing our novel glaucoma product candidates.”
The company has also appointed Dr. David Epstein as Chairman of its Scientific Advisory Board.